Characterization of glucose metabolism in youth with vs. without cystic fibrosis liver disease: A pilot study.
J Clin Transl Endocrinol
; 28: 100296, 2022 Jun.
Article
em En
| MEDLINE
| ID: mdl-35342717
APRI, Aspartate aminotransferase to Platelet Ratio Index; CAP, controlled attenuation parameter; CFRD, cystic fibrosis related diabetes; Cystic fibrosis; DM, diabetes; Diabetes; FFA, free fatty acids; Fib4, Fibrosis-4; GIP, gastric inhibitory polypeptide; GLP-1, glucagon like peptide-1; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; Hepatic insulin clearance; Insulin resistance; LD, liver disease, AUC, area under the curve; LSM, liver stiffness measurement; Liver disease; OGIS, oral glucose derived insulin sensitivity; OGTT, oral glucose tolerance test; Oral glucose tolerance test; VCTE, vibration controlled transient elastography; kPa, kilopascals
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Clin Transl Endocrinol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Estados Unidos